Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | 3-(1-Chloroethyl)-5-(3-chlorophenyl)-[1,2,4]oxadiazole | HCID 57837979 | — |
| Reactant | 3-Pyridin-4-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine | HCID 136117920 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 25006711 | HCID 25006711 | 22.1% |
Reaction Steps
NaH (716 mg, 29.8 mmol) was added slowly to a solution of 3-pyridin-4-yl-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrimidine (5.0 g, 24.8 mmol) in DMF (250 ml) under nitrogen. After 10 min a solution of 3-(1-chloroethyl)-5-(3-chlorophenyl)-1,2,4-oxadiazole (6.0 g, 24.8 mmol) in DMF (200 ml) was added, followed by stirring o.n. at r.t. A sat NH4Cl solution was added followed by water. The mixture was extracted with EA and DCM. The combined organic extracts were washed with water and brine, dried and concentrated. Recrystallization from EA gave 2.24 g (22%) of the racemic product 8-{1-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]ethyl}-3-pyridin-4-yl-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrimidine. Separation on a Chiralpak AD column (100% 2-propanol) gave the title compound which eluted as second enantiomer. 1H NMR: 1.74 (d, 3 H) 2.17 (m, 2 H) 3.45 (m, 2 H) 4.10 (m, 2 H) 5.96 (m, 1 H) 7.44 (t, 1 H) 7.53 (m, 1 H) 7.59 (m, 2 H) 7.97 (m, 1 H) 8.08 (m, 1 H) 8.67 (d, 2 H)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07585881B2 |
|---|
| Source dataset | uspto-grants-2009_09 |
|---|
| ORD ID | ord-5b2c2fb278004b3d87647c1f766468df |
|---|
| Source note | uspto-grants-2009_09 |
|---|